Global transcriptional response of macrophage-like THP-1 cells to Shiga toxin type

Infection and Immunity

Volumn 78, Issue 6, 2010, Pages 2454-2465

  Leyva Illades, Dinorah ^a   Cherla, Rama P ^a   Galindo, Cristi L ^b   Chopra, Ashok K ^c   Tesh, Vernon L ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^c University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; DUAL SPECIFICITY PHOSPHATASE; DUAL SPECIFICITY PHOSPHATASE 10; DUAL SPECIFICITY PHOSPHATASE 5; EARLY GROWTH RESPONSE FACTOR 1; ICOSANOID; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; PHOSPHATASE; SHIGA TOXIN; SHIGA TOXIN TYPE 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALGORITHM; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DATA ANALYSIS; ENZYME ACTIVATION; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; MACROPHAGE; MICROARRAY ANALYSIS; MONOCYTIC LEUKEMIA; MYELOID LEUKEMIA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TREATMENT RESPONSE; UPREGULATION; VALIDATION STUDY;

CELL LINE; ESCHERICHIA COLI PROTEINS; GENE EXPRESSION PROFILING; HUMANS; LIPOPOLYSACCHARIDES; MACROPHAGES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SHIGA TOXIN 1; STRESS, PHYSIOLOGICAL; UP-REGULATION;

EID: 77952697777     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01341-09     Document Type: Article

References (57)

1. Adler, S., and R. Bollu. 1998. Glomerular endothelial cell injury mediated by Shiga-like toxin-1. Kidney Blood Pressure Res. 21:13-21. (Pubitemid 28306437)
2. Boerlin, P., S. A. McEwen, F. Boerlin-Petzold, J. B. Wilson, R. P. Johnson, and C. L. Gyles. 1999. Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans. J. Clin. Microbiol. 37:497-503.
3. Cameron, P., S. J. Smith, M. A. Giembycz, D. Rotondo, and R. Plevin. 2003. Verotoxin activates mitogen-activated protein kinase in human peripheral blood monocytes: role in apoptosis and proinflammatory cytokine release. Br. J. Pharmacol. 140:1320-1330.
4. Cao, X., R. Mahendran, G. R. Guy, and Y. H. Tan. 1993. Detection and characterization of cellular EGR-1 binding to its recognition site. J. Biol. Chem. 268:16949-16957.
5. Cherla, R. P., S. Y. Lee, P. L. Mees, and V. L. Tesh. 2006. Shiga toxin 1-induced cytokine production is mediated by MAP kinase pathways and translation initiation factor eIF4E in the macrophage-like THP-1 cell line. J. Leukoc. Biol. 79:397-407.
6. Colpoys, W. E., B. H. Cochran, T. M. Carducci, and C. M. Thorpe. 2005. Shiga toxins activate translational regulation pathways in intestinal epithelial cells. Cell Signal. 17:891-899.
7. Foster, G. H., C. S. Armstrong, R. Sakiri, and V. L. Tesh. 2000. Shiga toxin-induced tumor necrosis factor alpha expression: requirement for toxin enzymatic activity and monocyte protein kinase C and protein tyrosine kinases. Infect. Immun. 68:5183-5189.
8. 2-terminal kinase and p38 in the human monocytic cell line THP-1: possible involvement in the production of TNF-alpha. J. Leukoc. Biol. 71:107-114.
9. Fraser, M. E., M. M. Chernaia, Y. V. Kozlov, and M. N. James. 1994. Crystal structure of the holotoxin from Shigella dysenteriae at 2.5 Å resolution. Nat. Struct. Biol. 1:59-64.
10. Fraser, M. E., M. Fujinaga, M. M. Cherney, A. R. Melton-Celsa, E. M. Twiddy, A. D. O'Brien, and M. N. James. 2004. Structure of Shiga toxin type 2 (Stx2) from Escherichia coli O157:H7. J. Biol. Chem. 279:27511-27517.
11. Guha, M., M. A. O'Connell, R. Pawlinski, A. Hollis, P. McGovern, S. F. Yan, D. Stern, and N. Mackman. 2001. Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression. Blood 98:1429-1439.
12. Harrison, L. M., R. P. Cherla, C. van den Hoogen, W. C. van Haaften, S. Y. Lee, and V. L. Tesh. 2005. Comparative evaluation of apoptosis induced by Shiga toxin 1 and/or lipopolysaccharides in human monocytic and macrophage-like cells. Microb. Pathog. 38:63-76.
13. Harrison, L. M., C. van den Hoogen, W. C. van Haaften, and V. L. Tesh. 2005. Chemokine expression in the monocytic cell line THP-1 in response to purified Shiga toxin 1 and/or lipopolysaccharides. Infect. Immun. 73:403-412.
14. Harrison, L. M., W. C. van Haaften, and V. L. Tesh. 2004. Regulation of proinflammatory cytokine expression by Shiga toxin 1 and/or lipopolysaccharides in the human monocytic cell line THP-1. Infect. Immun. 72:2618-2627.
15. Hebrant, A., W. C. van Staveren, L. Delys, D. W. Solis, T. Bogdanova, G. Andry, P. Roger, J. E. Dumont, F. Libert, and C. Maenhaut. 2007. Long-term EGF/serum-treated human thyrocytes mimic papillary thyroid carcinomas with regard to gene expression. Exp. Cell Res. 313:3276-3284.
16. Jean, S., C. Bideau, L. Bellon, G. Halimi, M. De Meo, T. Orsiere, G. Dumenil, J. L. Berge-Lefranc, and A. Botta. 2001. The expression of genes induced in melanocytes by exposure to 365-nm UVA: study by cDNA arrays and real-time quantitative RT-PCR. Biochim. Biophys. Acta 1522:89-96.
17. Jiang, Y. J., B. Lu, P. C. Choy, and G. M. Hatch. 2003. Regulation of cytosolic phospholipase A2, cyclooxygenase-1 and -2 expression by PMA, TNFα, LPS and M-CSF in human monocytes and macrophages. Mol. Cell. Biochem. 246:31-38.
18. Karmali, M. A. 1998. Human immune response and immunity to Shiga toxin (verocytotoxin)-producing Escherichia coli infection, p. 236-248. In J. B. Kaper and A. D. O'Brien (ed.), Escherichia coli O157:H7 and other Shiga toxin-producing E. coli strains. American Society for Microbiology, Washington, DC.
19. Keepers, T. R., L. K. Gross, and T. G. Obrig. 2007. Monocyte chemoattractant protein 1, macrophage inflammatory protein 1 alpha, and RANTES recruit macrophages to the kidney in a mouse model of hemolytic-uremic syndrome. Infect. Immun. 75:1229-1236.
20. Keepers, T. R., M. A. Psotka, L. K. Gross, and T. G. Obrig. 2006. A murine model of HUS: Shiga toxin with lipopolysaccharide mimics the renal damage and physiologic response of human disease. J. Am. Soc. Nephrol. 17:3404-3414.
21. Khachigian, L. M. 2006. Early growth response-1 in cardiovascular pathobiology. Circ. Res. 98:186-191.
22. Kim, Y. J., M. Song, and J. C. Ryu. 2009. Inflammation in methotrexate-induced pulmonary toxicity occurs via the p38 MAPK pathway. Toxicology 256:183-190.
23. Kojima, S., I. Yanagihara, G. Kono, T. Sugahara, H. Nasu, M. Kijima, A. Hattori, T. Kodama, K. I. Nagayama, and T. Honda. 2000. mkp-1 encoding mitogen-activated protein kinase phosphatase 1, a verotoxin 1 responsive gene, detected by differential display reverse transcription-PCR in Caco-2 cells. Infect. Immun. 68:2791-2796.
24. Koster, F., J. Levin, L. Walker, K. S. Tung, R. H. Gilman, M. M. Rahaman, M. A. Majid, S. Islam, and R. C. Williams, Jr. 1978. Hemolytic-uremic syndrome after shigellosis: relation to endotoxemia and circulating immune complexes. N. Engl. J. Med. 298:927-933.
25. -ΔΔCT method. Methods 25:402-408.
26. Locati, M., U. Deuschle, M. L. Massardi, F. O. Martinez, M. Sironi, S. Sozzani, T. Bartfai, and A. Mantovani. 2002. Analysis of the gene expression profile activated by the CC chemokine ligand 5/RANTES and by lipopolysaccharide in human monocytes. J. Immunol. 168:3557-3562. (Pubitemid 34250425)
27. Matussek, A., J. Lauber, A. Bergau, W. Hansen, M. Rohde, K. E. Dittmar, M. Gunzer, M. Mengel, P. Gatzlaff, M. Hartmann, J. Buer, and F. Gunzer. 2003. Molecular and functional analysis of Shiga toxin-induced response patterns in human vascular endothelial cells. Blood 102:1323-1332. (Pubitemid 36988039)
28. Morey, J. S., J. C. Ryan, and F. M. Van Dolah. 2006. Microarray validation: factors influencing correlation between oligonucleotide microarrays and real-time PCR. Biol. Proced. Online 8:175-193.
29. Nakahata, N. 2008. Thromboxane A2: physiology/pathophysiology, cellular signal transduction and pharmacology. Pharmacol. Ther. 118:18-35.
30. Nakao, H., and T. Takeda. 2000. Escherichia coli Shiga toxin. J. Nat. Toxins 9:299-313.
31. Ngiam, N., M. Post, and B. P. Kavanagh. 2007. Early growth response factor-1 in acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 293:L1089-L1091.
32. Owens, D. M., and S. M. Keyse. 2007. Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases. Oncogene 26:3203-3213. (Pubitemid 46763015)
33. Park, J. Y., M. H. Pillinger, and S. B. Abramson. 2006. Prostaglandin E2 synthesis and secretion: the role of PGE2 synthases. Clin. Immunol. 119:229-240.
34. Pavelka, M., J. Neumuller, and A. Ellinger. 2008. Retrograde traffic in the biosynthetic-secretory route. Histochem. Cell Biol. 129:277-288.
35. Pawlinski, R., B. Pedersen, B. Kehrle, W. C. Aird, R. D. Frank, M. Guha, and N. Mackman. 2003. Regulation of tissue factor and inflammatory mediators by Egr-1 in a mouse endotoxemia model. Blood 101:3940-3947. (Pubitemid 36857870)
36. Proulx, F., and V. L. Tesh. 2007. Renal diseases in the Pediatric Intensive Care Unit: thrombotic microangiopathy, hemolytic-uremic syndrome, and thrombotic thrombocytopenia purpura, p. 1189-1203. In D. S. Wheeler, H. R. Wong, and T. P. Shanley (ed.), Pediatric care medicine: basic science and clinical evidence. Springer-Verlag, London, England.
37. Ramegowda, B., J. E. Samuel, and V. L. Tesh. 1999. Interaction of Shiga toxins with human brain microvascular endothelial cells: cytokines as sensitizing agents. J. Infect. Dis. 180:1205-1213.
38. Ramegowda, B., and V. L. Tesh. 1996. Differentiation-associated toxin receptor modulation, cytokine production, and sensitivity to Shiga-like toxins in human monocytes and monocytic cell lines. Infect. Immun. 64:1173-1180.
39. Sakiri, R., B. Ramegowda, and V. L. Tesh. 1998. Shiga toxin type 1 activates tumor necrosis factor-alpha gene transcription and nuclear translocation of the transcriptional activators nuclear factor-κB and activator protein-1. Blood 92:558-566.
40. Sandvig, K. 2001. Shiga toxins. Toxicon 39:1629-1635.
41. Schmid, D. I., and D. E. Kohan. 2001. Effect of Shigatoxin-1 on arachidonic acid release by human glomerular epithelial cells. Kidney Int. 60:1026-1036.
42. Siegler, R. L., T. J. Pysher, V. L. Tesh, and F. B. Taylor. 2002. Renal prostacyclin biosynthesis in a baboon model of Shiga toxin mediated hemolytic-uremic syndrome. Nephron 92:363-368.
43. Stricklett, P. K., A. K. Hughes, Z. Ergonul, and D. E. Kohan. 2002. Molecular basis for up-regulation by inflammatory cytokines of Shiga toxin 1 cytotoxicity and globotriaosylceramide expression. J. Infect. Dis. 186:976-982.
44. Strockbine, N. A., L. R. Marques, J. W. Newland, H. W. Smith, R. K. Holmes, and A. D. O'Brien. 1986. Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities. Infect. Immun. 53:135-140.
45. Tam, P. J., and C. A. Lingwood. 2007. Membrane cytosolic translocation of verotoxin A1 subunit in target cells. Microbiology 153:2700-2710.
46. Tarr, P. I., C. A. Gordon, and W. L. Chandler. 2005. Shiga-toxin- producing Escherichia coli and hemolytic uraemic syndrome. Lancet 365:1073-1086.
47. Tesh, V. L., J. A. Burris, J. W. Owens, V. M. Gordon, E. A. Wadolkowski, A. D. O'Brien, and J. E. Samuel. 1993. Comparison of the relative toxicities of Shiga-like toxins type I and II for mice. Infect. Immun. 61:3392-3402.
48. Thiel, G., and G. Cibelli. 2002. Regulation of life and death by the zinc finger transcription factor Egr-1. J. Cell Physiol. 193:287-292. (Pubitemid 35265949)
49. Thorpe, C. M., W. E. Smith, B. P. Hurley, and D. W. Acheson. 2001. Shiga toxins induce, superinduce, and stabilize a variety of C-X-C chemokine mRNAs in intestinal epithelial cells, resulting in increased chemokine expression. Infect. Immun. 69:6140-6147.
50. Tonshoff, B., R. Momper, P. G. Kuhl, H. Schweer, K. Scharer, and H. W. Seyberth. 1990. Increased thromboxane biosynthesis in childhood hemolyticuremic syndrome. Kidney Int. 37:1134-1141. (Pubitemid 20106676)
51. Tsai, E. Y., J. V. Falvo, A. V. Tsytsykova, A. K. Barczak, A. M. Reimold, L. H. Glimcher, M. J. Fenton, D. C. Gordon, I. F. Dunn, and A. E. Goldfeld. 2000. A lipopolysaccharide-specific enhancer complex involving Ets, Elk-1, Sp1, and CREB binding protein and p300 is recruited to the tumor necrosis factor alpha promoter in vivo. Mol. Cell. Biol. 20:6084-6094.
52. Tsatsanis, C., A. Androulidaki, M. Venihaki, and A. N. Margioris. 2006. Signalling networks regulating cyclooxygenase-2. Int. J. Biochem. Cell Biol. 38:1654-1661.
53. Tsuchiya, S., M. Yamabe, Y. Yamaguchi, Y. Kobayashi, T. Konnom, and K. Tada. 1980. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int. J. Cancer 26:171-176. (Pubitemid 10086416)
54. van de Kar, N. C., L. A. Monnens, M. A. Karmali, and V. W. van Hinsbergh. 1992. Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic-uremic syndrome. Blood 80:2755-2764.
55. van Setten, P. A., V. W. van Hinsbergh, L. P. van den Heuvel, F. Preyers, H. B. Dijkman, K. J. Assmann, T. J. van der Velden, and L. A. Monnens. 1998. Monocyte chemoattractant protein-1 and interleukin-8 levels in urine and serum of patents with hemolytic-uremic syndrome. Pediatr. Res. 43:759-767.
56. Yao, J., N. Mackman, T. S. Edgington, and S. T. Fan. 1997. Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells: regulation by Egr-1, c-Jun, and NF-κB transcription factors. J. Biol. Chem. 272:17795-17801.
57. Zhang, L., J. R. Conejo-Garcia, D. Katsaros, P. A. Gimotty, M. Massobrio, G. Regnani, A. Makrigiannakis, H. Gray, K. Schlienger, M. N. Liebman, S. C. Rubin, and G. Coukos. 2003. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N. Engl. J. Med. 348:203-213.